William Budd
Internal Medicine · Saint Louis, MONPI 1861486953
Payments from drug & device makers
Across 242 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$463
- AstraZeneca$354
- Lilly USA, LLC$338
- Amgen$292
- Pfizer$248
- GSK$245
- plus $2K from 37 others
What the payments were for
- Food & beverage$4,150100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,150 in reported general payments places this provider in the 85th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 13 | $54,441 |
| EliquisApixaban | 24 | $19,557 |
| XareltoRivaroxaban | 14 | $7,557 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $6,487 |
| Atorvastatin Calcium | 143 | $1,838 |
| Losartan Potassium | 172 | $1,566 |
| Metformin Hcl | 83 | $1,023 |
| Levothyroxine Sodium | 63 | $903 |
| Amlodipine Besylate | 133 | $871 |
| Memantine Hcl | 24 | $868 |
| Pantoprazole Sodium | 27 | $810 |
| Isosorbide Dinitrate | 14 | $803 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $764 |
| Enalapril Maleate | 26 | $756 |
| Omeprazole | 58 | $588 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $248 | $19,55724 claims |
| Johnson & JohnsonXarelto | $142 | $7,55714 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $26217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Saint Louis
- Michael ReschakSaint Louis$3.1M
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
- Hany SalamaSaint Louis$279K
- Lauren LevineSaint Louis$264K
- Brij VaidSaint Louis$213K
- Vinay KamatSaint Louis$191K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
- Priyanka RavalSaint Louis$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.